Dermatological Therapeutics Market - Growths, Trends, and Forecasts (2020 - 2025)

Dermatological Therapeutics Market - Growths, Trends, and Forecasts (2020 - 2025)

With the rise in the aging population, dermatological care is likely to receive particular attention. As people age, the risk of developing skinrelated disorders increases, due to factors, such as changes in the connective tissue, reduction in the skin's strength and elasticity, and reduction in secretions from sebaceous glands.

Skin conditions pose a significant threat to patient’s wellbeing, mental health, ability to function, and social participation. The increasing incidence of dermatological diseases and increasing levels of awarenessrelated disease progression, etiology, and available therapies are leading to a high growth of dermatological therapeutics.

Key Market Trends

Atopic Dermatitis Segment is Expected to Register a Robust Growth

Atopic dermatitis is a widespread chronic inflammatory skin condition that can affect patients of all ages, and it is the result of multiple environmental, immunological, genetic, and pharmacologic factors. The disease mostly flares up when the patient is around the things that cause allergic reactions. The malfunctioning in the immune system of the human body, due to asthma, is also a major cause of atopic dermatitis. Due to several lifestyle factors, the global burden of atopic dermatitis is increasing rapidly, which, in turn, is fueling the growth of the segment.

North America Dominates the Market, in Terms of Revenue, and AsiaPacific is Expected to Register a Rapid Growth

North America is expected to lead the global market. Increasing healthcare expenditure, awareness about skin diseases, and the strong presence of pharmaceutical companies are anticipated to drive the market growth in North America. In AsiaPacific, the everincreasing pool of the patient population, increasing awareness, and increasing disposable incomes are expected to be pivotal to the robust market growth in the region.

Competitive Landscape

Many new players are emerging in the dermatological therapeutics market, as a result of a number of growth opportunities. Forthcoming patent expiries of major drugs are leading to increased competition, and it is further driving the market studied, especially in the generic sector. The overall dermatological diagnostics and therapeutics industry is expected to witness tremendous growth, with several generic players controlling significant market share in the developing regions.

Reasons to Purchase this report:

The market estimate (ME) sheet in Excel format
3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Dermatology Diseases
4.2.2 Increase in Awareness Levels of Disease Progression and Etiology
4.2.3 Increase in the Elderly Population
4.3 Market Restraints
4.3.1 Serious Side Effects for Certain Classes of Therapeutic Drugs
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Alopecia
5.1.2 Herpes
5.1.3 Psoriasis
5.1.4 Rosacea
5.1.5 Atopic Dermatitis
5.1.6 Other Applications
5.2 By Drug Class
5.2.1 Anti-infectives
5.2.2 Corticosteroids
5.2.3 Calcineurin Inhibitors
5.2.4 Retinoids
5.2.5 Other Drug Classes
5.3 By Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AbbVie Inc​.
6.1.2 Allergan PLC
6.1.3 Amgen Inc.
6.1.4 Almirall SA
6.1.5 Bausch Health Companies Inc.
6.1.6 Galderma SA
6.1.7 GlaxoSmithKline PLC
6.1.8 Johnson & Johnson
6.1.9 Novartis International AG
6.1.10 Pfizer Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook